Lung disease, such as chronic obstructive pulmonary disease (COPD) and asthma, plagues over 32.3 million United States citizens. It is estimated that treatment costs for asthma alone surpass $3.2 billion, putting a drain on consumer-patient’s bank accounts and our health system as a whole. At the Health Care Incentives Improvement Institute, we recognize the importance of encouraging more effective management and treatment of these conditions.
In response we’ve implemented both an Asthma Care and COPD Care Recognition Programs as part of our Bridges to Excellence Clinician Recognition Program. We place a special emphasis on managing patients with chronic conditions like Asthma and COPD, who are most at risk of incurring potentially avoidable complications and these programs measure the quality of care delivered in provider practices. In a nutshell, these programs are designed to help the best clinicians build their practices, help patients get healthier, help insurers and employers manage costs better.
But we know that addressing lung disease doesn’t stop at the doctor’s office. We need to get to the core of how we pay for these chronic diseases in addition to measuring quality. And we can do just that through the use of Evidence-informed Case Rates, or ECRs. These episode-of-care definitions can be applied for use in payment reform efforts and cost and quality analysis to accurately and efficiently redefine care delivery.
So how can these definitions be used? Since the definitions’ public release, we’ve held webinars that explore specific clinical domains covered by ECRs. Last month, we kicked off our 2015 ECR Clinical Webinar series with a focus on Heart Health as we dove into the development, design and real world use of cardiac episode definitions.
In February, we turn our concentration to Pulmonary Episodes with Dr. Christopher Sistrom, Associate Professor of Radiology at University of Florida, Gainesville and Distinguished Scientist, Schneider Institute for Health Policy at Brandeis University and Dr. Amita Rastogi, HCI3 Medical Director. On Wednesday, February 18th at 5 p.m. ET, together they will take a deeper look into these pulmonary ECRs by focusing on asthma, COPD and pneumonia episode design and application.
We invite you to join to see how these episodes can advance your efforts and ask our experts your questions about their experiences with ECRs.